Adapthealth (NASDAQ: AHCO) reported second quarter EPS of $0.09, $0.04 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $793.3M versus the consensus estimate of $765.16M.
Guidance
Adapthealth sees FY 2023 revenue of $3.16M-$3.20M versus the analyst consensus of $3.14M.
Adapthealth's stock price closed at $13.30. It is up 31.81% in the last 3 months and down -40.20% in the last 12 months.
https://in.investing.com/news/adapthealth-earnings-missed-by-004-revenue-topped-estimates-3761287
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.